• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, COSTA RICA LTDA (SH) SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, COSTA RICA LTDA (SH) SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-23A
Device Problems Calcified (1077); Material Erosion (1214)
Patient Problem Aortic Insufficiency (1715)
Event Date 12/01/2020
Event Type  Injury  
Manufacturer Narrative
The results/ method and conclusion codes along with investigation results will be provided in the final report.
 
Event Description
Degeneration of a trifecta 5tf-23a, that had been implanted in (b)(6) 2015 was determined.The valve was explanted and replaced on (b)(6) 2020 with a 21 mm regent valve.Upon explant calcification at the top of the stent pins was present and confirmed.The patient remained stabled throughout the procedure and no patient consequences were reported.
 
Manufacturer Narrative
The reported calcification was confirmed.All leaflets contained calcifications and associated tears.All leaflets were fibrotically thickened.Fibrous pannus ingrowth was noted on the outflow surface covering stent posts 1 and 2 and encroaching onto leaflets 1 and 2, and on the inflow surface of leaflet 2.The leaflet mobility was limited due to the calcifications and pannus.No inflammation was present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.While the calcifications and associated leaflet tears are consistent with the reported degeneration, the host to device reaction (pannus formation), along with the selected valve size (23 mm) larger than the replacement valve (21 mm), are possible evidence of interaction with patient anatomy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, COSTA RICA LTDA (SH)
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 01897 -405
CS  01897-4050
MDR Report Key11066267
MDR Text Key223431455
Report Number3008452825-2020-00704
Device Sequence Number1
Product Code LWR
UDI-Device Identifier05414734052030
UDI-Public05414734052030
Combination Product (y/n)N
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Replace
Type of Report Initial,Followup
Report Date 02/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/23/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/09/2017
Device Model NumberTF-23A
Device Catalogue NumberTF-23A
Device Lot Number4998893
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received02/04/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age57 YR
-
-